5AM Venture Management
5AM Venture Management reported 16 stocks worth $297M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are LTGO (41.2%), TRDA (8.1%) and TYRA (7.6%). Compared with Q2 2026, the fund opened new positions in LTGO and SKYE, trimmed TRDA, CAMP and PHVS and sold out of SRZN and SKYE.
Latest filing: what 5AM Venture Management did in Q3 2026
vs Q2 2026None
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() LTGO Latigo Biotherapeutics | $122M | 41.2% | 7.3M | New position | 1 of 8 | |
| 2 | ![]() TRDA Entrada Therapeutics Inc | $24M | 8.1% | 3.8M | −272K (−7%) | 8 of 8 | |
| 3 | ![]() TYRA Tyra Biosciences Inc | $22.5M | 7.6% | 1M | No change | 8 of 8 | |
| 4 | ![]() CAMP CAMP4 Therapeutics Corp | $21.3M | 7.2% | 5.3M | −592K (−10%) | 8 of 8 | |
| 5 | ![]() ARTV Artiva Biotherapeutics Inc | $16.8M | 5.6% | 2.4M | No change | 8 of 8 | |
| 6 | ![]() PHVS Pharvaris N V | $15.2M | 5.1% | 480K | −318K (−40%) | 8 of 8 | |
| 7 | ![]() TECX Tectonic Therapeutic Inc | $14.1M | 4.8% | 607K | No change | 8 of 8 | |
| 8 | ![]() CLDX Celldex Therapeutics Inc | $13.7M | 4.6% | 422K | −75K (−15%) | 8 of 8 | |
| 9 | ![]() ZNTL Zentalis Pharmaceuticals Inc | $10.9M | 3.7% | 3.9M | No change | 8 of 8 | |
| 10 | ![]() BHVN Biohaven Ltd | $9.9M | 3.3% | 739K | No change | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() SRZN Surrozen Inc | $7M | 271K |
![]() SKYE Skye Bioscience Inc | $6.7M | 9.7M |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →5AM Venture Management 13F FAQ
What does 5AM Venture Management own?
5AM Venture Management reported 16 stocks worth $297M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are LTGO (41.2%), TRDA (8.1%) and TYRA (7.6%). The table above lists every position in the filing (the top 10 without an account).
What did 5AM Venture Management buy and sell in Q3 2026?
Compared with Q2 2026: 2 new positions, 0 added to, 5 trimmed and 2 sold out. New positions include LTGO and SKYE. It sold all of SRZN and SKYE.
When will 5AM Venture Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is 5AM Venture Management's portfolio worth?
The Q3 2026 filing reports $297M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.












